These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 24556697)
1. Exendin-4 alleviates high glucose-induced rat mesangial cell dysfunction through the AMPK pathway. Xu WW; Guan MP; Zheng ZJ; Gao F; Zeng YM; Qin Y; Xue YM Cell Physiol Biochem; 2014; 33(2):423-32. PubMed ID: 24556697 [TBL] [Abstract][Full Text] [Related]
2. High glucose stimulates cell proliferation and Collagen IV production in rat mesangial cells through inhibiting AMPK-K Zhang B; Shi YQ; Zou JJ; Chen XF; Tang W; Ye F; Liu ZM Int Urol Nephrol; 2017 Nov; 49(11):2079-2086. PubMed ID: 28748494 [TBL] [Abstract][Full Text] [Related]
3. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation. Zhou Y; He X; Chen Y; Huang Y; Wu L; He J Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):394-9. PubMed ID: 26519882 [TBL] [Abstract][Full Text] [Related]
4. [Effects of exendin-4 on extracellular matrix metabolism in human mesangial cells cultured in high glucose]. Xiao ZZ; Guan MP; Zheng ZJ; Jia YJ; Wang L; Xue YM Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):371-4. PubMed ID: 27063165 [TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway. Yang S; Lin C; Zhuo X; Wang J; Rao S; Xu W; Cheng Y; Yang L Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1019-E1030. PubMed ID: 32985256 [TBL] [Abstract][Full Text] [Related]
6. Exendin-4 reverses high glucose-induced endothelial progenitor cell dysfunction via SDF-1β/CXCR7-AMPK/p38-MAPK/IL-6 axis. Yang Y; Zhou Y; Wang Y; Wei X; Wu L; Wang T; Ma A Acta Diabetol; 2020 Nov; 57(11):1315-1326. PubMed ID: 32556532 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the expression of TGF-β1 and CTGF in human mesangial cells by exendin-4, a glucagon-like peptide-1 receptor agonist. Li W; Cui M; Wei Y; Kong X; Tang L; Xu D Cell Physiol Biochem; 2012; 30(3):749-57. PubMed ID: 22890152 [TBL] [Abstract][Full Text] [Related]
8. Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner. Wei R; Ma S; Wang C; Ke J; Yang J; Li W; Liu Y; Hou W; Feng X; Wang G; Hong T Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E947-57. PubMed ID: 27072494 [TBL] [Abstract][Full Text] [Related]
9. Exenatide inhibits the growth of endometrial cancer Ishikawa xenografts in nude mice. Zhang Y; Xu F; Liang H; Cai M; Wen X; Li X; Weng J Oncol Rep; 2016 Mar; 35(3):1340-8. PubMed ID: 26648451 [TBL] [Abstract][Full Text] [Related]
10. AMPK-mediated downregulation of connexin43 and premature senescence of mesangial cells under high-glucose conditions. Guo YN; Wang JC; Cai GY; Hu X; Cui SY; Lv Y; Yin Z; Fu B; Hong Q; Chen XM Exp Gerontol; 2014 Mar; 51():71-81. PubMed ID: 24423443 [TBL] [Abstract][Full Text] [Related]
11. PAS kinase is a nutrient and energy sensor in hypothalamic areas required for the normal function of AMPK and mTOR/S6K1. Hurtado-Carneiro V; Roncero I; Egger SS; Wenger RH; Blazquez E; Sanz C; Alvarez E Mol Neurobiol; 2014 Oct; 50(2):314-26. PubMed ID: 24445950 [TBL] [Abstract][Full Text] [Related]
12. Exendin-4 upregulates the expression of Wnt-4, a novel regulator of pancreatic β-cell proliferation. Heller C; Kühn MC; Mülders-Opgenoorth B; Schott M; Willenberg HS; Scherbaum WA; Schinner S Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E864-72. PubMed ID: 21771967 [TBL] [Abstract][Full Text] [Related]
13. Calcium/calmodulin-dependent serine protein kinase is involved in exendin-4-induced insulin secretion in INS-1 cells. Zhu ZQ; Wang D; Xiang D; Yuan YX; Wang Y Metabolism; 2014 Jan; 63(1):120-6. PubMed ID: 24140090 [TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 analogs activate AMP kinase leading to reversal of the Warburg metabolic switch in breast cancer cells. Ligumsky H; Amir S; Arbel Rubinstein T; Guion K; Scherf T; Karasik A; Wolf I; Rubinek T Med Oncol; 2024 May; 41(6):138. PubMed ID: 38705935 [TBL] [Abstract][Full Text] [Related]
15. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose. Burmeister MA; Ayala J; Drucker DJ; Ayala JE Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495 [TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes. Kodera R; Shikata K; Kataoka HU; Takatsuka T; Miyamoto S; Sasaki M; Kajitani N; Nishishita S; Sarai K; Hirota D; Sato C; Ogawa D; Makino H Diabetologia; 2011 Apr; 54(4):965-78. PubMed ID: 21253697 [TBL] [Abstract][Full Text] [Related]
17. Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents. Arakawa M; Ebato C; Mita T; Hirose T; Kawamori R; Fujitani Y; Watada H Biochem Biophys Res Commun; 2009 Dec; 390(3):809-14. PubMed ID: 19836346 [TBL] [Abstract][Full Text] [Related]
18. The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism. Andreozzi F; Raciti GA; Nigro C; Mannino GC; Procopio T; Davalli AM; Beguinot F; Sesti G; Miele C; Folli F J Transl Med; 2016 Jul; 14(1):229. PubMed ID: 27473212 [TBL] [Abstract][Full Text] [Related]
19. AMP-activated protein kinase (AMPK) activation inhibits nuclear translocation of Smad4 in mesangial cells and diabetic kidneys. Zhao J; Miyamoto S; You YH; Sharma K Am J Physiol Renal Physiol; 2015 May; 308(10):F1167-77. PubMed ID: 25428125 [TBL] [Abstract][Full Text] [Related]
20. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway. Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]